Features,
Health Matters,
Red Cross,
Calendar,
West Nile Virus,
Honors & Awards,
Announcements
Health & Fitness News Elsewhere
(fresh daily from the Web)
|
Features
|
HHS acts to reduce potential risks of dietary
supplements containing ephedra
[MARCH
1, 2003]
On Friday the Department of
Health and Human Services, HHS, announced a series of actions
designed to protect Americans from potentially serious risks of
dietary supplement products containing ephedra.
|
The results of a RAND Corporation study
commissioned by the National Institutes of Health, as well as other
recent studies, provide additional evidence that ephedra may be
associated with important health risks. The RAND report also finds
only limited evidence of health benefits resulting from ephedra use.
On the basis of new evidence in the
medical literature and in adverse event reports, there are reasons
for heightened concern that dietary supplements containing ephedra
may present a significant and unreasonable risk of illness and
injury.
To protect Americans from the
potentially serious risks of these dietary supplements, HHS and the
Food and Drug Administration are going to:
--Seek rapid public comment on the new
evidence on health risks associated with ephedra in order to
establish an up-to-date record as quickly as possible to support new
restrictions on ephedra-containing products.
--Seek rapid public comment on whether
the currently available evidence and medical literature present a
"significant or unreasonable risk of illness or injury" from dietary
supplements containing ephedra.
--Seek rapid comment on a strong new
warning label on any ephedra products that continue to be marketed.
--Immediately execute a series of
actions against ephedra products making unsubstantiated claims about
sports performance enhancement.
In addition, the nation's top public
health officials issued strong statements cautioning about the use
of ephedra-containing products, especially under conditions of
strenuous exercise and in combination with other stimulants,
including caffeine.
"We want to caution all Americans --
particularly athletes and those who engage in strenuous activities
-- about using dietary supplements that contain ephedra," said
Secretary of Health and Human Services Tommy G. Thompson. "There
continue to be serious questions about the risks surrounding this
particular dietary supplement."
"FDA will do all we can to protect
Americans from potentially dangerous dietary supplements," said
Commissioner of Food and Drugs Mark B. McClellan, M.D., Ph.D. "We
are particularly concerned about the risks of using products
containing ephedra during heavy workouts, with caffeine and other
stimulants, in a diet program that stresses the cardiovascular
system, or by people under the age of 18. We are also concerned
about potential stresses to the body caused by the long-term use of
ephedra. The standard for regulating the safety of dietary
supplements is largely untested, but we are committed to finding the
right public health solution."
Ephedra is a naturally occurring
substance derived from the Chinese herbal Ma Huang. Its principal
active ingredient is ephedrine, which when chemically synthesized is
regulated as a drug. While products containing natural ephedrine
alkaloids have long been used to treat certain respiratory symptoms
in traditional Chinese medicine, in recent years they been
extensively promoted and used with the goals of aiding weight loss,
enhancing sports performance and increasing energy.
Many of today's proposed actions
involve a
Federal Register notice, which went on display Friday, reopening
for 30 days the comment period on a draft regulation FDA first
proposed in 1997 and modified in 2000. [The notice is in Adobe
Acrobat.
Click
here to download the Adobe Acrobat reader.]
FDA's concerns about dietary
supplements containing ephedra arise in part from ephedra's
mechanism of action in the body. Ephedra is an adrenaline-like
stimulant that can have potentially dangerous effects on the nervous
system and heart.
In addition, evidence is accumulating
about potentially serious safety problems following the use of
ephedra-containing products. The RAND study has concluded that
ephedra is associated with higher risks of mild to moderate side
effects, such as heart palpitations, psychiatric and upper
gastrointestinal effects, and symptoms of autonomic hyperactivity,
such as tremor and insomnia, especially when it is taken with other
stimulants.
Moreover, its review of some 16,000
adverse event reports revealed two deaths, four heart attacks, nine
strokes, one seizure and five psychiatric cases involving ephedra in
which the records appeared thorough and no other contributing
factors were identified. RAND called such cases "sentinel events,"
because they may indicate a safety problem but do not prove that
ephedra caused the adverse event. The study recognized that such
case studies are a weak form of scientific evidence. Other
unmeasured factors may have contributed, and such serious adverse
events are likely to happen (albeit at very low rates) among the
millions of users of ephedra anyway. The study also identified other
such events potentially associated with ephedra in which other
factors may have contributed to the adverse events or in which
records were inadequate.
Two recent studies of ephedra's safety
were published too late to be included in the RAND Corporation's
review, and each raises further concerns about ephedra. One,
published this month in the Annals of Internal Medicine, found that
although ephedra-products make up less than one percent of all
dietary supplement sales, these products account for 64 percent of
adverse events associated with dietary supplements.
Another "case-control" study, published
in the journal Neurology, concluded that for people who take doses
above 32 milligrams a day, the rate of hemorrhagic (bleeding)
strokes among ephedra users was statistically significantly higher
than among nonusers. Many ephedra dietary supplement labels
recommend that users take up to approximately 100 mg of ephedra
daily.
Additional relevant evidence on whether
the current system of regulating ephedra's safety is adequate comes
from results under FDA's more extensive regulation of synthetic
ephedrine, which is identical to the main active ingredient in
ephedra. Ephedrine has long been available in some FDA-approved
over-the-counter and prescription drugs. It appears that the more
controlled availability of synthetic ephedrine products, which are
available primarily for approved uses for respiratory symptoms and
carry mandatory warning labels, has not been associated with the
same kind of severe adverse events as have occurred with dietary
supplements containing ephedra. This long experience with synthetic
ephedrine (in over-the-counter drug products, not in dietary
supplements) suggests that significant restrictions on labeling,
marketing and access to ephedrine might effectively address
unreasonable risks associated with certain forms of ephedra today.
[to top of second
column in this article]
|
"Although the overall evidence suggests
that serious adverse events from ephedra appear to be infrequent, we
know that such events can be very serious and possibly fatal," said
Dr. McClellan. "We believe that the current scientific evidence
strongly suggests that at least some ephedra products present an
unreasonable risk. We also believe that FDA's system for regulating
synthetic versions of the chemicals in ephedra appears to have a
much better track record of safety. To give us the strongest
possible basis for further regulatory action, we are asking for
quick comments on whether these dietary supplements present an
unreasonable risk of harm and whether it makes sense for FDA to seek
new authority in this area."
Under the Dietary Supplement Health and
Education Act of 1994, FDA does not review dietary supplements for
safety and effectiveness before they are marketed. Rather, the law
allows FDA to prohibit sale of a dietary supplement if it "presents
a significant or unreasonable risk of injury." This legal standard
of "significant or unreasonable risk" implies a risk-benefit
calculation based on the best available scientific evidence. It
strongly suggests that the agency must determine if a product's
known or supposed risks outweigh any known or suspected benefits,
based on the available scientific evidence, in light of the claims
the product makes and in light of the product's being sold directly
to consumers without medical supervision.
In seeking comment on these issues, FDA
is reopening a proposed rule entitled "Dietary Supplements
Containing Ephedrine Alkaloids." That proposal would have required a
warning statement for these products, as well as restrictions on
their potency and composition. FDA later withdrew parts of this
proposed rule because of concerns expressed by the General
Accounting Office about the specific scientific evidence in the
proposal.
In a broad action against potentially
dangerous products, FDA sent more than two dozen warning letters on
Friday to firms marketing dietary supplements that contain ephedrine
alkaloids. The letters, targeted particularly at products making
claims for athletic performance, explain that any claims their
products make about effects on the structure and function of the
human body must be truthful and not misleading. They outline FDA's
view in light of the RAND report that the claims being made are not
adequately substantiated by scientific data, and they direct the
companies to submit any data supporting the claims within 15 days.
The letters also warn firms that they
must not make claims about their products' ability to treat or cure
a disease or condition such as obesity. Under the Federal Food, Drug
and Cosmetic Act, unapproved products making these "disease claims"
are unapproved new drugs and therefore subject to other prompt
regulatory actions, including injunctions against firms and seizures
of their products.
FDA will also continue to work closely
with the Federal Trade Commission to ensure that dietary supplement
products containing ephedra do not make false and misleading claims.
"If an ad says a product is 'safe,' the advertisers must have
competent and reliable evidence to prove the claim," said Timothy J.
Muris, chairman of the Federal Trade Commission. "Consumers depend
on advertising for information. Deceptive ad claims can put a
consumer's health at risk. That's why we will pursue aggressively
marketers making deceptive claims about the safety or effectiveness
of products."
On Friday the FDA also proposed a
warning label for all ephedra-containing dietary supplements. The
proposed label warns about the risks of serious adverse events,
including heart attack, seizure, stroke and death; cautions that the
risk can increase with the dose, with strenuous exercise and with
other stimulants such as caffeine; specifies certain groups (such as
women who are pregnant or breast-feeding) who should never use these
products; and lists other conditions, such as diseases and the use
of certain medications, that rule out the use of ephedrine
alkaloids.
"The steps being announced today
demonstrate FDA's commitment to taking the most effective actions
possible under current law, given the state of the scientific
evidence," said Dr. McClellan. "It may be possible to use ephedra
safely, in small doses, for some purposes. But in the face of
continued serious adverse events following the use of ephedra, there
is a problem. It is a problem we are determined to fix."
Once the 30-day comment period has
ended, FDA will analyze the comments and publish its conclusions
about the most appropriate approach to reducing the risk of using
dietary supplement products containing ephedrine alkaloids.
The National Advisory Council for the
National Center for Complementary and Alternative Medicine, part of
NIH, is meeting March 17 to assess the evidence on ephedra's safety
and effectiveness in order to develop a research agenda on ephedra.
FDA will give that committee an opportunity to comment on Friday's
notice if the committee finds it appropriate to do so.
All interested parties may send the FDA
written comments on these issues involving ephedra until April 7.
Comments may be sent electronically to
www.fda.gov/dockets/ecomments or by regular mail to Dockets
Management Branch (HFA-305), Food and Drug Administration, 5630
Fishers Lane, Room 1061, Rockville, MD 20852.
Additional materials about the risks of
products containing ephedrine alkaloids, including a more technical
FDA "white paper," may be found on FDA's website at the following
addresses:
[Food
and Drug Administration press release] |
|
|
What
you need to know about ephedra
[FEB.
22, 2003]
Ephedrine, also known as
ephedra or ma huang, has injured or killed 800 users.
|
Products containing ephedrine
Super Cap & White Cross
Yellow Jacket
Black Beauty
What
is ephedrine?
What are ephedrine, ephedra and ma
huang?
These terms are used to refer to the
same substance derived from the plant ephedra. Ephedrine supplements
are derived from the dried branches of the plant known as ephedra.
Ephedra grows primarily in Mongolia and parts of China. In the
United States, ephedra and ephedrine are sold in health food stores
under a variety of brand names. Ephedrine is widely used for weight
loss, as an energy booster and to enhance athletic performance.
These products often contain other stimulants, such as caffeine,
which may have collective effects and increase the potential for
adverse effects.
Ephedra contains ephedrine, a stimulant
that acts on the central nervous system. It is found in products
such as Metabolife, Yellow Jackets, Stacker 2, Black Beauties and
other products. The FDA believes that ephedra may be related to
numerous deaths. Most of the serious injuries involve high blood
pressure that can cause bleeding in the brain, a stroke or a heart
attack. Ephedrine alkaloids are amphetaminelike compounds used in
over-the-counter and prescription drugs with potentially lethal
stimulant effects on the central nervous system and heart.
Dangers
Ephedra is one of the most dangerous of
the dietary supplements. People continue to believe that because
herbs are "natural" they are harmless. Dietary supplements may
interact with prescription, as well as over-the-counter,
medications. However, many dietary remedies are dangerous, such as
creatine.
There is limited research evaluating
creatine's safety and usefulness. The FDA does not regulate creatine,
an over-the-counter drug that has been marketed to enhance sport
performance. Adverse effects associated with the use of creatine
include muscle strain, stomach upsets and kidney problems.
Recent studies show that many people
are seriously injured by the use of ephedrine. They are often
unaware that ephedrine suppliers can make wide-ranging health claims
about the product that have no scientific basis.
FDA
warnings
No-Doz and Vivarin are other types of
over-the-counter drugs that advertise increased alertness. These
caffeine tablets can cause nausea, insomnia, tremors, irritability,
depression, chest pain and dizziness.
"The FDA is warning consumers not to
purchase or consume ephedrine-containing dietary supplements with
labels that often portray the products as apparent alternatives to
illegal street drugs such as 'ecstasy.' Possible adverse effects of
ephedrine range from clinically significant effects such as heart
attack, stroke, seizures, psychosis and death, to clinically less
significant effects that may indicate the potential for more serious
effects (for example: dizziness, headache, gastrointestinal
distress, irregular heartbeat and heart palpitations). Ingredient
panels on these products may list ma huang, Chinese ephedra, ma
huang extract, ephedra, ephedra sinica, ephedra extract, ephedra
herb powder or epitonin, all [of] which indicate a source of
ephedrine."
[to top of second
column in this article]
|
Dietary supplements do not need
approval from the FDA before they are marketed. Also, manufacturers
do not need to register themselves or their dietary supplement
products with the FDA before producing or selling them.
Deceptive marketing
A law known as the Dietary Supplements
Health and Education Act, which was passed in 1994, prevents the FDA
from regulating these products. Prior to this act about supplements,
the FDA claimed it had the power to regulate them and tried to make
the manufacturers and suppliers prove their safety claims for their
products.
The use of herbs in the United States
has increased dramatically since the passage of the act. In 1997, 60
million Americans spent $3.24 billion on herbs for reasons such as
migraines, hypertension, depression, weight loss and sexual stamina.
An estimated 15 million adults are at risk for potential herb-drug
interactions.
Deceptive marketing occurs when the
supplement industry selects brand names or uses wording on labels
such as "fat burner" or "detoxifies" or "natural ecstasy" to suggest
the impossible.
Contact the FDA
If you think you, or someone you know,
have suffered a serious harmful effect or illness from a product the
FDA regulates, including dietary supplements, the first thing you
should do is contact or see your health care provider immediately.
Then you and your health care provider are encouraged to report this
problem to the FDA. You, or anyone, may report a serious adverse
event or illness directly to the FDA, by calling 1 (800) FDA-1088 or
by fax to 1 (800) FDA-0178. The identity of the reporter or patient
is kept confidential.
If you, or
someone you know, is addicted to any drug, contact Logan-Mason
Mental Health for treatment options.
[Logan-Mason Mental Health]
This pamphlet material was developed by
Kristi Lessen, N.I.S., Logan-Mason Mental Health substance abuse
prevention specialist, in collaboration with Richard Alexander,
M.D., medical director of Mental Health Centers of Central Illinois
and medical director of Memorial Behavioral Health Group. The
pamphlet is paid for in part by the Illinois Department of Human
Services.
Logan-Mason Mental Health
(A division of Mental Health Centers of
Central Illinois)
304 Eighth St.
Lincoln, IL 62656
(217) 735-2272
|
|
Health Matters
A monthly feature from
Logan County Health Department
|
A preventable cancer
[MARCH
4, 2003]
|
The facts
Colorectal cancer -- cancer of the
colon or rectum -- is the second leading cause of cancer deaths in
the United States. In 2002, there will be approximately 148,300
colorectal cancer diagnoses, and 56,600 people are expected to die
from the disease.
But you can take steps to protect
yourself from the disease:
More than 90 percent of colorectal cancer is preventable.
Colorectal cancers can develop in both
men and women. More than 90 percent of cases are found in people
over the age of 50.
Risk
factors
Since people are more likely to get
colorectal cancer as they get older, everyone age 50 or over should
undergo regular screening for the disease. Some people, however,
have a higher risk of colorectal cancer.
If you fall into one of the following
groups, you should talk to your health care provider about starting
colorectal cancer screening at an earlier age:
--Personal or family history of
colorectal cancer, polyps or inflammatory bowel disease.
--Personal or family history of
ovarian, endometrial or breast cancer.
African-Americans have higher
colorectal cancer incidence and death rates than other ethnic
groups, in part because they are less likely to be screened for the
disease.
Screening
for prevention
Following colorectal screening
recommendations can detect polyps -- grapelike growths on the lining
of the colon and rectum that can become cancerous. Removing these
polyps can prevent colorectal cancer from ever developing.
There are four common tests used to
screen for colorectal cancer. Your health care provider can help you
decide which test is best for you.
A fecal occult blood test is a
simple chemical test that finds blood present in stool samples. You
can perform an FOBT yourself at home with a kit that you can get
from your health care provider and send to a laboratory for results.
This testing is recommended every year.
While an FOBT tests for warning signs
in the stool, the three tests described below look inside the body
to find polyps.
Flexible sigmoidoscopy
is a visual examination of the rectum and lower portion of the
colon, performed in a health care provider’s office or in a clinic
or hospital. A flexible tube about the thickness of your finger is
put into the anus and slowly moved into the rectum and lower part of
the colon. Your health care provider can view the area by looking
through the eyepiece of the tube. This testing is recommended every
five years.
Colonoscopy
is like a sigmoidoscopy, but it lets
your health care provider examine the lining of your entire colon
rather than just its lower portion. Removal of polyps can be
performed during colonoscopy to prevent cancer. This testing is
recommended every five to 10 years.
A double-contrast barium enema
uses an X-ray to look at the colon and is performed in a hospital or
clinic. The double-contrast technique involves injecting a liquid
called barium sulfate and air into the rectum in order to get a view
of the large intestine. This testing is recommended testing every
five to 10 years.
Symptoms
Although colorectal cancer can develop
without symptoms, there are some warning signs for the disease.
If you have any of these symptoms,
contact your health care provider for testing:
- Rectal bleeding
- Blood in or around your stool
- A change in the shape of your
stool
- Stomach discomfort, including
bloating, fullness or cramps
- Unexplained weight loss or
fatigue
[to top of second column in this
article]
|
Prevention tips
Since how you live affects your health,
you can take steps to help lower your risk for colorectal cancer.
Healthy dietary choices, being active and regular screening can help
lower your risk.
While regular screening is your best
bet for lowering your risk, research suggests that being physically
active can help protect against the disease. In addition to exercise
and maintaining a healthy weight, eating a low-fat diet full of
fruits, vegetables and whole grains may help prevent colorectal
cancer.
Staying away from tobacco and alcohol
can also lower your risk. In 2002, 170,000 Americans are expected to
die from colorectal and other cancers caused by tobacco use. If you
don’t smoke, don’t start, and if you do smoke, quit. And if you
drink, do so in moderation; aim for one drink or less per day.
National
Colorectal Cancer Awareness Month
March is National Colorectal Cancer
Awareness Month, founded by the Cancer Research and Prevention
Foundation in collaboration with many partner organizations. The
campaign to designate the special month was launched in March 2000.
The goal is to generate widespread awareness about colorectal cancer
prevention through screening and healthy lifestyle choices.
Colorectal cancer is preventable. It is
easy to treat and often curable when detected early. Talk with your
health care professional about colorectal cancer.
To learn more, visit
http://www.preventcancer.org/colorectal/.
Colorectal cancer myths and realities
Myth:
There is nothing I can do about getting
colorectal cancer.
Reality:
Colorectal cancer can be prevented.
Screening tests can detect polyps (grapelike growths on the lining
of the colon or rectum) that can turn into cancer. Removing these
polyps can prevent colorectal cancer from ever occurring. Starting
at age 50, men and women who are at average risk should be screened
regularly for colorectal cancer. Men and women who are at high risk
of the disease may need to be tested earlier and should talk to
their health care professional about when.
Myth:
Colorectal cancer is usually fatal.
Reality:
Colorectal cancer is usually curable
when detected early. More than 90 percent of patients with localized
colorectal cancer confined to the colon or rectum are alive five
years after diagnosis.
Myth:
Colorectal cancer is a disease of older
white men.
Reality:
An equal number of women and men get
colorectal cancer. An estimated 75,700 women and 72,600 men were
diagnosed with colorectal cancer in 2002. African-Americans are more
likely to be diagnosed with colorectal cancer at later stages of the
disease.
Myth:
Screening tests are necessary only for
individuals who have symptoms.
Reality:
Since symptoms of colorectal
cancer are often silent, it is important to get screened regularly.
Screenings test for a disease even if the patient has no symptoms.
About 75 percent of all new cases of colorectal cancer occur in
individuals with no known risk factors for the disease, other than
being 50 or older. If you have a personal or family history of
colorectal cancer, polyps or inflammatory bowel disease, you may
need to be screened before age 50. Talk with your health care
professional.
[From the
Logan County Health
Department]
All information in this article was
provided by the Cancer Research Foundation of America, 1600 Duke
St., Suite 110, Alexandria, VA 22314;
(703) 836-4412;
www.preventcancer.org.
|
|
|
Red Cross
|
|
West Nile Virus
|
West Nile virus links
|
LDN articles
Federal websites
|
State websites
|
|
Honors & Awards
|
|
Announcements
|
CICBC
blood drives monthly at paramedics' building
Schedule for 2003 announced
Blood supplies across the
nation are critical. In some areas, there is less than a one-day
supply. Fortunately, thanks to the dedicated donors in central
Illinois, these tremendous shortages have not yet touched our
hospitals. However, the blood supply is a resource that must be
renewed. Every three seconds someone needs a blood transfusion of
some kind. To accommodate this constant usage, community members
must continually help replenish the supply. Since a donor can donate
whole blood only every eight weeks, Central Illinois Community Blood
Center needs community members to come forward and help with this
lifesaving effort.
|
Central Illinois Community Blood Center
provides all of the blood and blood products for 12 area hospitals,
including those in Lincoln, Hopedale and Springfield. No other
organization provides blood in these hospitals. CICBC is a
community-based blood center whose mission is to provide a safe and
adequate blood supply for patients in local hospitals in a
cost-effective manner.
When you donate blood through CICBC,
you help to keep a safe and adequate blood supply for your
community. You also help keep local medical costs under control.
Regularly scheduled blood drives are on the first Monday of each
month (except Labor Day) at the Logan County Paramedics Association
building, 1300 N. Postville Road. (See
2003 schedule below.) Please help by donating blood.
[to top of second
column in this article]
|
CICBC will also bring its automated
double red cell machine, and if donors are interested in platelet
apheresis, information will be available. If there is enough
interest, CICBC will bring apheresis machines to Lincoln.
CICBC also provides other services for
the communities served, such as therapeutic phlebotomy at no charge
for patients with hereditary hemochromatosis.
For more
information, call Terry Bell at 753-1530.
[CICBC press release]
|
|
CICBC blood drive schedule |
-
March 12,
hours and location to be announced
-
April 7,
noon-6 p.m., at Logan County Paramedics Association building
-
April 11,
at Lincoln Community High School
-
May 5,
noon-6 p.m., at Logan County Paramedics Association building
-
May 14,
hours and location to be announced
-
June 2,
noon-6 p.m., at Logan County Paramedics Association building
-
July 7,
noon-6 p.m., at Logan County Paramedics Association building
-
July 15,
hours and location to be announced
-
Aug. 4,
noon-6 p.m., at Logan County Paramedics Association building
[to top of second
column in this section]
|
-
Sept. 8,
noon-6 p.m., at Logan County Paramedics Association building
-
Sept. 24,
hours and location to be announced
-
Oct. 6,
noon-6 p.m., at Logan County Paramedics Association building
-
Nov. 3,
noon-6 p.m., at Logan County Paramedics Association building
-
Nov. 12,
hours and location to be announced
-
Dec. 1,
noon-6 p.m., at Logan County Paramedics Association building
|
|
|
Mobile health unit schedule
The
Rural Health Partnership has announced the schedule for its mobile
health unit for 2002.
|
Morning: 9-11 a.m. |
|
Afternoon: 1-3:30 p.m. |
Monday |
1st and 3rd |
Hartsburg |
1st and 3rd |
Emden |
|
2nd and 4th |
San Jose |
2nd and 4th |
Greenview |
Tuesday |
Weekly |
Chestnut |
Weekly |
Mount Pulaski |
Wednesday |
Weekly |
New Holland |
Weekly |
Middletown |
Thursday |
1st and 3rd |
Elkhart |
Weekly |
Atlanta |
|
2nd and 4th |
Friendship
Manor-Lincoln |
|
|
Friday |
1st, 2nd,
4th |
Village Hall-Latham |
1st |
Beason |
|
|
|
2nd and 4th |
Broadwell |
|
3rd |
Maintenance/ special
events |
3rd |
Maintenance/
special events
|
The mobile health unit does not operate on the following dates for
holidays during 2002: Jan. 21 (Martin Luther King Jr. Day), Feb.
18 (Presidents' Day), March 29 (Good Friday), May 27 (Memorial Day),
July 4 (Independence Day), Sept. 2 (Labor Day), Oct. 14 (Columbus
Day), Nov. 11 (Veterans Day), Nov. 28-29 (Thanksgiving break) and Dec.
24-25 (Christmas break).
For more
information on the mobile health unit schedule and services, contact
Dayle Eldredge at (217) 732-2161, Ext. 409.
|
|
Community resource list
This family
resource list to save and use is provided by the Healthy Communities
Partnership and the
Healthy Families Task Force, 732-2161, Ext. 409.
Agency |
Phone number |
Address |
Lincoln
agencies |
911 |
911 (emergency)
732-3911 (office -- non-emergency)
|
911 Pekin St.
Lincoln, IL 62656
|
Abraham Lincoln
Memorial Hospital
|
732-2161
|
315 Eighth St.
Lincoln, IL 62656
|
American Red Cross
www.il-redcross.org |
732-2134 or
1 (800) 412-0100
|
125 S. Kickapoo
Lincoln, IL 62656
|
Catholic Social
Services
www.cdop.org |
732-3771 |
310 S. Logan
Lincoln, IL 62656
|
Lincoln/Logan County
Chamber
of Commerce
www.lincolnillinois.com |
735-2385 |
303 S. Kickapoo St.
Lincoln, IL 62656
|
Community Action (CIEDC) |
732-2159
|
1800 Fifth St.
Lincoln, IL 62656
|
Crisis Pregnancy
Center/
Living Alternatives |
735-4838 |
408 A Pulaski St.
Lincoln, IL 62656
|
DCFS (Department of
Children
& Family Services) |
735-4402 or
1 (800) 252-2873
(crisis hotline)
|
1120 Keokuk St.
Lincoln, IL 62656
|
Heartland Community
College
- GED program |
735-1731 |
620 Broadway St.
Lincoln, IL 62656
|
Housing Authority |
732-7776
|
1028 N. College St.
Lincoln, IL 62656
|
Illinois Breast &
Cervical Cancer Program (IBCCP)
www.logancountyhealth.org |
735-2317 or
1 (800) 269-4019
|
109 Third St.
Lincoln, IL 62656
|
Illinois Employment and Training Center (replaces JTPA office) |
735-5441 |
120 S. McLean St., Suite B
Farm Bureau Building
Lincoln, IL 62656
|
Lincoln Area YMCA
|
735-3915 |
319 W. Kickapoo St.
Lincoln, IL 62656
|
Lincoln/Logan Food
Pantry |
732-2204
|
P.O. Box 773
Lincoln, IL 62656
|
Lincoln Parents' Center |
735-4192 |
100 S. Maple
Lincoln, IL 62656
|
Lincoln Park District |
732-8770 |
1400 Primm Rd.
Lincoln, IL 62656
|
Logan County Department
of Human Services (Public Aid)
www.state.il.us/agency/dhs |
735-2306 |
1500 Fourth St.
P.O. Box 310
Lincoln, IL 62656
|
Logan County Health
Department
www.logancountyhealth.org |
735-2317 |
109 Third St.
P.O. Box 508
Lincoln, IL 62656
|
Logan-Mason Mental
Health |
735-2272 or
732-3600 (crisis line)
|
304 Eighth St.
Lincoln, IL 62656
|
Logan-Mason
Rehabilitation Center |
735-1413 |
760 S. Postville Drive
Lincoln, IL 62656
|
The Oasis
(Senior Citizens of Logan County) |
732-6132 |
501 Pulaski St.
Lincoln, IL 62656
|
Project READ
|
735-1731 |
620 Broadway St.
Lincoln, IL 62656
|
Salvation Army |
732-7890
|
1501 N. Kickapoo
Lincoln, IL 62656
|
Senior Services of
Central Illinois |
732-6213 or
1 (800) 252-8966
(crisis line)
|
109 Third St.
Lincoln, IL 62656
|
U. of I. Extension
Service
www.ag.uiuc.edu |
732-8289 |
980 N. Postville Drive
Lincoln, IL 62656
|
Springfield
agencies |
Department of Aging
www.state.il.us/aging |
785-3356 |
421 E. Capitol, #100
Springfield, IL 62701-1789
|
American Cancer Society
www.cancer.org |
546-7586
(24 hour) |
1305 Wabash, Suite J
Springfield, IL 62704
|
Community Child Care
Connection
www.childcaresolutions.org |
(217) 525-2805 or
1 (800) 676-2805
|
1004 N. Milton Ave.
Springfield, IL 62702-4430
|
Hospice Care of
Illinois |
1 (800) 342-4862
(24 hour) or
732-2161, Ext. 444
|
720 N. Bond
Springfield, IL 62702
|
Illinois Department of
Public Health
www.idph.state.il.us |
(217) 782-4977
|
535 W. Jefferson
Springfield, IL 62761
|
Legal Assistance
Foundation |
(217) 753-3300 or
1 (800) 252-8629
|
730 E. Vine St., Suite
214
Springfield, IL 62703
|
Sojourn Shelter &
Services Inc.
http://www.sojournshelter.org/
|
732-8988 or
1 (866) HELP4DV
(24-hour hotline)
|
1800 Westchester Blvd.
Springfield, IL 62704
|
U. of I. Division of
Specialized Care for Children
www.uic.edu |
524-2000 or
1 (800) 946-8468
|
421 South Grand Ave.
West
Second Floor
Springfield, IL 62704
|
Logan County
libraries |
Atlanta Library |
(217) 648-2112 |
100 Race St.
Atlanta, IL 61723 |
Elkhart Library |
(217) 947-2313 |
121 E. Bohan
Elkhart, IL 62634 |
Lincoln Public Library
www.lincolnpubliclibrary.org |
732-8878 |
725 Pekin St.
Lincoln, IL 62656 |
Mount Pulaski Library |
792-5919
|
320 N. Washington
Mount Pulaski, IL 62548
|
|
(updated
2-15-02) |
Back to top |
News |
Sports | Business
| Rural Review |
Teaching & Learning |
Home and Family |
Tourism |
Obituaries
Community |
Perspectives |
Law & Courts |
Leisure Time |
Spiritual Life |
Health & Fitness |
Calendar
Letters to the Editor
|
|